References
- Vermont Oxford Network. Vermont Oxford Network Annual Report: Section 2, Table 2.5. Burlington, VT: Vermont Oxford Network; 2010.
- Bose CL, Laughon MM. Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed. 2007;92(6):F498–F502.
- Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol. 2010;30(4): 241–252.
- Benitz WE. Patent ductus arteriosus: to treat or not to treat? Arch Dis Child Fetal Neonatal Ed. 2012;97(2):F80–F82.
- Horbar JD, Rogowski J, Plsek PE, et al. Collaborative quality improvement for neonatal intensive care. Pediatrics. 2001;107(1):14–22.
- Spear S, Bowen HK. Decoding the DNA of the Toyota production system. Harv Bus Rev. 1999;77(5):97–106.
- Auerbach AD, Landefeld CS, Shojania KG. The tension between needing to improve care and knowing how to do it. New Engl J Med. 2007;357(6):608–613.
- Walsh M, Laptook A, Kazzi SN, et al. A cluster-randomized trial of benchmarking and multimodal quality improvement to improve rates of survival free of bronchopulmonary dysplasia for infants with birth weights of less than 1250 grams. Pediatrics. 2007;119(5):876–890.
- Payne NR, Finkelstein MJ, Liu M, Kaempf JW, Sharek PJ, Olsen S. NICU practices and outcomes associated with 9 years of quality improvement collaboratives. Pediatrics. 2010;125(3):437–446.
- Institute of Medicine, Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academies Press; 2001.
- Kaempf JW, Wu YX, Kaempf AJ, Kaempf AM, Wang L, Grunkemeier G. What happens when the patent ductus arteriosus is treated less aggressively in very low birth weight infants? J Perinatol. 2012;32(5):344–348.
- Vermont Oxford Network. Manual of Operations for Infants Born in 2010: Release 14.0. Burlington, VT: Vermont Oxford Network; 2009. Available from: http://www.vtoxford.org/tools/2010Manualof0peratio nswithindex14.pdf. Accessed February 1, 2013.
- Sosenko IR, Fajardo MF, Claure N, Bancalari E. Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial. J Pediatr. 2012;160(6): 929–935.
- Van Cleave J, Dougherty D, Perrin JM. Strategies for addressing barriers to publishing pediatric quality improvement research. Pediatrics. 2011;128(3):e678–e686.
- Berwick DM. The science of improvement. JAMA. 2008;299(10): 1182–1184.
- Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ. 1996;312(7040):1215–1218.
- Davidoff F. Systems of service: reflections on the moral foundations of improvement. BMJ Qual Saf. 2011;20(Suppl 1):i5–i10.
- Chassin MR, Loeb JM, Schmaltz SP, Wachter RM. Accountability measures – using measurement to promote quality improvement. New Engl J Med. 2010;363(7):683–688.
- Rauh SS, Wadsworth EB, Weeks WB, Weinstein JN. The savings illusion – why clinical quality improvement fails to deliver bottom-line results. New Engl J Med. 2011;365(26):e48.
- De Buyst J, Rakza T, Pennaforte T, Johansson AB, Storme L. Hemodynamic effects of fluid restriction in preterm infants with significant patent ductus arteriosus. J Pediatr. 2012;161(3):404–408.
- Clyman RI. Mechanisms regulating the ductus arteriosus. Biol Neonate. 2006;89(4):330–335.
- Chen S, Tacy T, Clyman R. How useful are B-type natriuretic peptide measurements for monitoring changes in patent ductus arteriosus shunt magnitude? J Perinatol. 2010;30(12):780–785.
- McNamara PJ, Sehgal A. Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed. 2007;92(6):F424–F427.